Therapeutic Drug Monitoring of Ganciclovir: Where Are We?

Ganciclovir is the mainstay of therapy for the prophylaxis and treatment of Cytomegalovirus. However, therapy with this antiviral agent is hindered by side effects such as myelosuppression, which often leads to therapy cessation. Underdosing, as an attempt to prevent side effects, can lead to drug r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Therapeutic drug monitoring Jg. 44; H. 1; S. 138
Hauptverfasser:	Märtson, Anne-Grete, Edwina, Angela E, Kim, Hannah Yejin, Knoester, Marjolein, Touw, Daan J, Sturkenboom, Marieke G G, Alffenaar, Jan-Willem C
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.02.2022
Schlagworte:	Antiviral Agents - adverse effects Cytomegalovirus Infections - drug therapy Drug Monitoring - methods Ganciclovir - therapeutic use Humans Valganciclovir - pharmacokinetics Valganciclovir - therapeutic use
ISSN:	1536-3694, 1536-3694
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!